| MiR-3606-3p inhibits systemic sclerosis through targeting TGF-beta type II receptor | |
| Shi, Xiangguang; Liu, Qingmei; Li, Na; Tu, Wenzhen; Luo, Ruoyu; Mei, Xueqian; Ma, Yanyun; Xu, Weihong; Chu, Haiyan; Jiang, Shuai | |
| 刊名 | CELL CYCLE
 |
| 2018 | |
| 卷号 | 17期号:16 |
| 关键词 | Fibrosis miR-3606-3p TGF-beta type II receptor cell proliferation |
| ISSN号 | 1538-4101 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3609033 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Shi, Xiangguang,Liu, Qingmei,Li, Na,et al. MiR-3606-3p inhibits systemic sclerosis through targeting TGF-beta type II receptor[J]. CELL CYCLE,2018,17(16). |
| APA | Shi, Xiangguang.,Liu, Qingmei.,Li, Na.,Tu, Wenzhen.,Luo, Ruoyu.,...&Wang, Jiucun.(2018).MiR-3606-3p inhibits systemic sclerosis through targeting TGF-beta type II receptor.CELL CYCLE,17(16). |
| MLA | Shi, Xiangguang,et al."MiR-3606-3p inhibits systemic sclerosis through targeting TGF-beta type II receptor".CELL CYCLE 17.16(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论